Celldex Therapeutics Inc
NASDAQ:CLDX
Celldex Therapeutics Inc
Revenue
Celldex Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
Revenue
$6.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Celldex Therapeutics Inc
Revenue Breakdown
Breakdown by Geography
Celldex Therapeutics Inc
Breakdown by Segments
Celldex Therapeutics Inc
Total Revenue:
6.9m
USD
|
Grant:
6.6m
USD
|
Service:
278k
USD
|
See Also
What is Celldex Therapeutics Inc's Revenue?
Revenue
6.9m
USD
Based on the financial report for Dec 31, 2023, Celldex Therapeutics Inc's Revenue amounts to 6.9m USD.
What is Celldex Therapeutics Inc's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 192%. The average annual Revenue growth rates for Celldex Therapeutics Inc have been -2% over the past three years , -6% over the past five years , and 5% over the past ten years .